Eligibility checklist - Adlimumab
This form covers a 24-month trial of adalimumab with the understanding that patients will be reviewed regularly with a formal assessment of response at six months.
This form covers a 24-month trial of adalimumab with the understanding that patients will be reviewed regularly with a formal assessment of response at six months.